Managing perioperative arrhythmias in noncardiac surgery
Arrhythmias can appear before, during, or after a noncardiac operation, even in patients without a documented history of rhythm disease. Surgical stress, anesthetic drugs, hypoxemia, electrolyte abnormalities, blood loss, infection, and rapid changes in sympathetic tone can destabilize cardiac electrophysiology. The clinical challenge is to distinguish a transient response to a reversible trigger from a rhythm that signals myocardial injury or requires urgent treatment.
A practical perioperative strategy combines risk assessment, appropriate monitoring, prompt correction of physiological disturbances, and rhythm-specific therapy. The goal is not to suppress every ectopic beat. It is to preserve perfusion, identify dangerous instability, reduce thromboembolic risk, and avoid treatments that create additional bradycardia, hypotension, or proarrhythmia.
Clinicians can consult the Journal of Arrhythmia for peer-reviewed research and educational material covering electrophysiology, ablation, pacing, implantable devices, and clinical management. These resources can support local protocols while decisions remain individualized to the operation, comorbidities, and goals of care.
Why rhythm disturbances emerge around surgery
The perioperative period exposes the heart to several simultaneous stressors. Intubation, incision, emergence from anesthesia, pain, agitation, and hypothermia can increase catecholamine activity. Conversely, neuraxial anesthesia, vagal stimulation, opioid administration, and some sedatives may produce clinically important slowing of the sinus or atrioventricular node. Arrhythmogenic conditions may therefore change quickly as the patient moves between anesthetic and recovery phases.
Common precipitating factors include potassium or magnesium depletion, acid–base disturbance, hypoxia, hypercarbia, anemia, fever, sepsis, myocardial ischemia, and acute ventricular strain. Fluid shifts and vasopressors can alter atrial and ventricular loading conditions. Medication interactions also matter: antiemetics, antimicrobials, psychotropic drugs, and anesthetic agents may lengthen the QT interval or interact with established antiarrhythmic therapy.
The significance of a perioperative arrhythmia depends on rate, duration, ventricular function, symptoms, and hemodynamic effect. A brief episode of atrial tachycardia in a stable patient may need observation and correction of its trigger. New ventricular tachycardia, profound bradycardia, or atrial fibrillation with shock requires immediate assessment and, when necessary, synchronized cardioversion or advanced resuscitation.
Preoperative risk assessment and preparation
The preoperative evaluation should document previous atrial fibrillation, supraventricular tachycardia, syncope, ventricular arrhythmia, inherited rhythm syndromes, pacemaker or defibrillator implantation, structural heart disease, and prior ablation. Review the baseline electrocardiogram for rhythm, conduction intervals, QRS duration, ischemic changes, and QT correction. An echocardiogram or specialist consultation may be appropriate when symptoms, reduced ventricular function, significant valve disease, or unexplained syncope are present.
Medication reconciliation needs particular attention. Determine whether beta-blockers, calcium-channel blockers, digoxin, antiarrhythmic drugs, or anticoagulants should be continued, withheld, or adjusted. Abrupt withdrawal of chronic rate-control therapy can provoke tachycardia, while continuing several nodal-blocking agents in a volume-depleted patient can cause severe hypotension or bradycardia. The plan for direct oral anticoagulants, warfarin, and heparin bridging should account for bleeding risk, renal function, thromboembolic risk, and the urgency of surgery.
Patients with implantable devices require an explicit perioperative plan. Electromagnetic interference from monopolar electrosurgery can inhibit pacing or trigger inappropriate implantable cardioverter-defibrillator therapy. Device interrogation, reprogramming, magnet use, dispersive-pad positioning, and postoperative restoration of original settings should involve an experienced team. External defibrillation and pacing equipment should be available when device therapies are suspended.
Intraoperative monitoring and reversible triggers
The intensity of monitoring should match the patient’s risk and the procedure’s physiological burden. Continuous electrocardiography and pulse oximetry are standard for general anesthesia, while invasive arterial pressure monitoring may be warranted for major surgery, severe structural heart disease, unstable arrhythmia history, or anticipated rapid blood loss. A defibrillator with synchronized cardioversion and transcutaneous pacing capability should be immediately accessible when clinically significant rhythm disease is possible.
When an arrhythmia develops, begin with the patient rather than the monitor. Confirm a pulse and assess blood pressure, oxygenation, mental status, surgical bleeding, and signs of ischemia. Check the electrocardiographic tracing in more than one lead when possible, because artifact can mimic atrial flutter or ventricular tachycardia. Stop or reduce provoking stimulation, improve oxygenation and ventilation, and ask the surgical team to pause if the rhythm is associated with instability.
Laboratory evaluation commonly includes potassium, magnesium, calcium, glucose, hemoglobin, blood gas analysis, and markers of ischemia when indicated. Correct hypovolemia, anemia, hypoxia, and severe electrolyte abnormalities. Magnesium replacement can be useful in torsades de pointes or significant QT prolongation, while potassium should generally be maintained in a safe high-normal range in patients at risk for ventricular arrhythmia. Avoid stacking QT-prolonging drugs and review the complete medication list before administering rescue therapy.
Recognizing and treating common rhythms
A narrow-complex regular tachycardia may represent atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia, or atrial flutter with fixed conduction. In a stable patient, vagal maneuvers are sometimes possible, and adenosine may clarify or terminate an atrioventricular node-dependent rhythm when used with appropriate monitoring. It usually will not terminate atrial fibrillation or flutter, but transient atrioventricular block can reveal the underlying atrial activity. Unstable supraventricular tachycardia requires synchronized cardioversion.
New atrial fibrillation is common after major thoracic, abdominal, vascular, and orthopedic procedures. Evaluate for hypoxia, infection, ischemia, volume disturbance, pain, and electrolyte depletion before selecting rate or rhythm control. Rate control may be reasonable in a stable patient, but hypotension, heart failure, bronchospasm, or pre-excitation can limit beta-blockers, nondihydropyridine calcium-channel blockers, or digoxin. Cardioversion is indicated for hemodynamic instability; anticoagulation decisions should consider episode duration, stroke risk, recurrence, and surgical bleeding.
A wide-complex tachycardia should be treated as ventricular tachycardia until a reliable diagnosis proves otherwise, particularly in a patient with structural heart disease. If there is no pulse, follow the cardiac arrest algorithm with immediate defibrillation when indicated. If a pulse is present but the patient is unstable, perform synchronized cardioversion. Stable cases still require urgent expert review, a 12-lead ECG, and consideration of ischemia, electrolyte imbalance, drug toxicity, and pre-excitation.
| Rhythm or finding | Immediate priorities | Typical next step |
|---|---|---|
| Sinus bradycardia or AV block | Check oxygenation, vagal triggers, drugs, ischemia, and potassium | Observe if stable; treat symptomatic bradycardia with atropine or pacing pathway |
| Atrial fibrillation or flutter | Assess blood pressure, ischemia, heart failure, duration, and triggers | Correct causes; rate or rhythm control if stable, synchronized cardioversion if unstable |
| Regular narrow-complex tachycardia | Confirm stability and regularity; obtain a 12-lead ECG | Vagal maneuvers or adenosine when appropriate; cardioversion for instability |
| Wide-complex tachycardia | Assume ventricular tachycardia until clarified; assess pulse | Defibrillation for pulseless rhythm, synchronized cardioversion if unstable with a pulse |
| Polymorphic VT or torsades | Stop QT-prolonging drugs; correct magnesium, potassium, and ischemia | Intravenous magnesium and urgent defibrillation when sustained or unstable |
Postoperative surveillance and stroke prevention
The risk of arrhythmia often persists after the operation, when pain, hypoventilation, shivering, fever, and fluid shifts continue. Patients with new atrial fibrillation, significant ventricular ectopy, prolonged QT, conduction disease, or a difficult intraoperative event may need monitored recovery or telemetry rather than routine ward observation. Repeated ECGs can document persistence, recurrence, or conversion and help guide medication changes.
Postoperative delirium, weakness, dyspnea, chest discomfort, and hypotension may be manifestations of an arrhythmia rather than ordinary recovery. Nursing and surgical teams should know the warning signs and escalation pathway. A rhythm strip should be saved during an event, and the record should include timing, hemodynamic effects, medications, laboratory values, and response to treatment.
Anticoagulation after postoperative atrial fibrillation is individualized. Stroke-risk assessment remains important, but immediate full anticoagulation may be hazardous after intracranial, neuraxial, major vascular, or high-bleeding-risk surgery. Decisions should involve surgery, anesthesia, cardiology, and the patient when feasible, with a clear plan for reassessment as hemostasis improves. Follow-up is appropriate when the episode lasts, recurs, exposes previously unknown atrial disease, or occurs in a patient with substantial stroke risk. Evidence summaries and themed collections available through the journal’s special issues can help clinicians review evolving questions in perioperative electrophysiology.
Practical recommendations
A concise protocol improves consistency during an event and reduces delays caused by uncertainty. It should define who confirms the rhythm, who leads airway and circulation management, how cardioversion equipment is obtained, and when electrophysiology or cardiology consultation is required. Simulation training can be particularly useful for rare but high-consequence situations such as torsades, malignant ventricular tachycardia, and device-related emergencies.
- Obtain a baseline ECG and identify prior arrhythmias, structural heart disease, conduction abnormalities, QT prolongation, and implanted devices.
- Correct hypoxia, hypovolemia, anemia, potassium or magnesium depletion, acid–base disturbance, pain, fever, and medication-related triggers.
- Treat the patient’s hemodynamic condition first, using synchronized cardioversion or defibrillation promptly when instability or cardiac arrest is present.
- Review anticoagulant interruption and restart plans with surgical, anesthesia, and medical teams rather than applying a fixed schedule.
- Document the rhythm, precipitating factors, treatment, device management, and follow-up plan before discharge.
Perioperative arrhythmia care is strongest when prevention and emergency response are treated as one process. A carefully prepared team can recognize meaningful rhythm deterioration early, avoid unnecessary antiarrhythmic exposure, and coordinate postoperative monitoring with long-term stroke and sudden-death risk assessment.
Clinicians and trainees can use the Journal of Arrhythmia’s open-access research, reviews, guidelines, and educational collections to strengthen institutional pathways and support evidence-informed decisions in daily practice. Examine the relevant literature when updating protocols, and ensure every patient leaves the perioperative pathway with a documented rhythm assessment and follow-up plan.